Research and Markets: Ophthalmology Therapeutics in Major Developed Markets 2013-2019 - US, UK, France, Germany, Italy, Spain, Japan and Canada

Research and Markets (http://www.researchandmarkets.com/research/9pr5w7/ophthalmology) has announced the addition of the "Ophthalmology Therapeutics in Major Developed Markets 2013-2019 - US, UK, France, Germany, Italy, Spain, Japan and Canada" report to their offering.

Ophthalmology Therapeutics in Major Developed Markets 2013-2019 - US, UK, France, Germany, Italy, Spain, Japan and Canada provides insights into two therapeutic indications in ophthalmology in Top Eight Markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada.

The top five European markets (the UK, France, Germany, Italy and Spain) are expected to show the fastest growth over the forecast period, with a CAGR of 20.4%. The other three markets are expected to see similar but slightly lower CAGRs, with Canada at 9.8%, the US at 4.3%, and Japan at 2.7%. The US had the largest market in 2012, with a value of $1.9 billion, or 52% of the total ophthalmology market. The next-largest market was Japan with $1,065m or 29% of the total Major Markets. In the same year, the top five European markets were valued at $549m, a share of 15%. Canada had the lowest market share at 4%, with a market value of $144m.

The report provides an in-depth analysis of the therapeutic indications of ophthalmology, namely glaucoma and Dry Eye Syndrome (DES). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these two ophthalmology indications.

Scope

• Disease overview and treatment usage patterns
• Market size and forecast for glaucoma and DES in Top Eight Markets (the US, the UK, France, Germany, Italy, Spain, Japan and Canada) from 2012 to 2019
• Major marketed products for the indications types covered
• In-depth pipeline analysis for glaucoma and DES
• Key drivers and restraints that have had and are expected to have a significant impact upon the market
• Key licensing and co-development agreements in the ophthalmology market

Key Topics Covered:

1. Tables & Figures
2. Ophthalmology Therapeutics in Major Markets - Introduction
3. Ophthalmology Therapeutics in Major Markets - Marketed Products (Global)
4. Ophthalmology Therapeutics in Major Markets - Pipeline Analysis
5. Ophthalmology Therapeutics in Major Markets - Market Forecast to 2019
6. Ophthalmology Therapeutics in Major Markets - Deals and Strategic Consolidations (Global)
7. Ophthalmology Therapeutics in Major Markets - Appendix

For more information visit http://www.researchandmarkets.com/research/9pr5w7/ophthalmology